Ananya Datta-Mitra1, Smriti Kundu-Raychaudhuri1, Anupam Mitra2, Siba P Raychaudhuri1. 1. Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis, School of Medicine, Davis, CA, 95616, United States of America; VA Medical Center Sacramento, Mather, CA, 95655, United States of America. 2. VA Medical Center Sacramento, Mather, CA, 95655, United States of America; Department of Dermatology, University of California Davis, School of Medicine, Sacramento, CA, 95817, United States of America.
Abstract
BACKGROUND: Increasing evidence points to a role for the extra-neuronal nerve growth factor (NGF) in acquired immune responses. However, very little information is available about its role and underlying mechanism in innate immunity. The role of innate immunity in autoimmune diseases is becoming increasingly important. In this study, we explored the contribution of pleiotropic NGF in the innate immune response along with its underlying molecular mechanism with respect to IL-1β secretion. METHODS: Human monocytes, null and NLRP3 deficient THP-1 cell lines were used for this purpose. We determined the effect of NGF on secretion of IL-1β at the protein and mRNA levels. To determine the underlying molecular mechanism, the effect of NGF on NLRP1/NLRP3 inflammasomes and its downstream key protein, activated caspase-1, were evaluated by ELISA, immunoflorescence, flow cytometry, and real-time PCR. RESULTS: In human monocytes and null THP-1 cell line, NGF significantly upregulates IL-1β at protein and mRNA levels in a caspase-1 dependent manner through its receptor, TrkA. Furthermore, we observed that NGF induces caspase-1 activation through NLRP1/NLRP3 inflammasomes, and it is dependent on the master transcription factor, NF-κB. CONCLUSIONS: To best of our knowledge, this is the first report shedding light on the mechanistic aspect of a neuroregulatory molecule, NGF, in innate immune response, and thus enriches our understanding regarding its pathogenic role in inflammation. These observations add further evidence in favor of anti-NGF therapy in autoimmune diseases and also unlock a new area of research about the role of NGF in IL-1β mediated diseases.
BACKGROUND: Increasing evidence points to a role for the extra-neuronal nerve growth factor (NGF) in acquired immune responses. However, very little information is available about its role and underlying mechanism in innate immunity. The role of innate immunity in autoimmune diseases is becoming increasingly important. In this study, we explored the contribution of pleiotropic NGF in the innate immune response along with its underlying molecular mechanism with respect to IL-1β secretion. METHODS:Human monocytes, null and NLRP3 deficient THP-1 cell lines were used for this purpose. We determined the effect of NGF on secretion of IL-1β at the protein and mRNA levels. To determine the underlying molecular mechanism, the effect of NGF on NLRP1/NLRP3 inflammasomes and its downstream key protein, activated caspase-1, were evaluated by ELISA, immunoflorescence, flow cytometry, and real-time PCR. RESULTS: In human monocytes and null THP-1 cell line, NGF significantly upregulates IL-1β at protein and mRNA levels in a caspase-1 dependent manner through its receptor, TrkA. Furthermore, we observed that NGF induces caspase-1 activation through NLRP1/NLRP3 inflammasomes, and it is dependent on the master transcription factor, NF-κB. CONCLUSIONS: To best of our knowledge, this is the first report shedding light on the mechanistic aspect of a neuroregulatory molecule, NGF, in innate immune response, and thus enriches our understanding regarding its pathogenic role in inflammation. These observations add further evidence in favor of anti-NGF therapy in autoimmune diseases and also unlock a new area of research about the role of NGF in IL-1β mediated diseases.
Authors: Rebeccah J Mathews; James I Robinson; Michele Battellino; Chi Wong; John C Taylor; Steve Eyre; Sarah M Churchman; Anthony G Wilson; John D Isaacs; Kimme Hyrich; Anne Barton; Darren Plant; Sinisa Savic; Graham P Cook; Piercarlo Sarzi-Puttini; Paul Emery; Jennifer H Barrett; Ann W Morgan; Michael F McDermott Journal: Ann Rheum Dis Date: 2013-05-17 Impact factor: 19.103
Authors: Z Zhai; W Liu; M Kaur; Y Luo; J Domenico; J M Samson; Y G Shellman; D A Norris; C A Dinarello; R A Spritz; M Fujita Journal: Oncogene Date: 2017-03-06 Impact factor: 9.867
Authors: Donald B Hoover; Thomas Christopher Brown; Madeleine K Miller; John B Schweitzer; David L Williams Journal: Front Immunol Date: 2017-12-06 Impact factor: 7.561
Authors: Ayse Kizilyer; Meera V Singh; Vir B Singh; Sumanun Suwunnakorn; James Palis; Sanjay B Maggirwar Journal: Sci Rep Date: 2019-02-26 Impact factor: 4.379
Authors: Santiago G Lago; Jakub Tomasik; Geertje F van Rees; Jordan M Ramsey; Frieder Haenisch; Jason D Cooper; Jantine A Broek; Paula Suarez-Pinilla; Tillmann Ruland; Bonnie Auyeug; Olya Mikova; Nikolett Kabacs; Volker Arolt; Simon Baron-Cohen; Benedicto Crespo-Facorro; Sabine Bahn Journal: Mol Psychiatry Date: 2018-07-23 Impact factor: 13.437